FDA approved Vaxelis, a new combination DTaP-IPV-Hib-HepB vaccine for use in children 6 wks-4 yrs of age
On Dec. 26, 2018, Sanofi announced the U.S. Food and Drug Administration (FDA) had approved VAXELIS (Diphtheria and…
Karmanos Cancer Institute and Wayne State University awarded prestigious LAPS grant
On Dec. 20, 2018, the Karmanos Cancer Institute and Wayne State University were awarded the prestigious LAPS Grant…
Karmanos Morey Cancer Center recognized by the American Society of Clinical Oncology with the QOPI Certification Program
On Dec. 17, 2018, the Karmanos Morey Cancer Center was recognized by the American Society of Clinical Oncology…
The UK announced sequencing 100,000 whole genomes in the National Health Service
On Dec. 15, 2018, Genomics England announced the 100,000 Genomes Project, done in partnership with National Health Service…
The Allen Institute for Immunology was founded
On Dec. 12, 2018, the Allen Institute announced the launch of the Allen Institute for Immunology, a new…
Record $50 million gift to Virginia Tech results in naming of the Fralin Biomedical Research Institute in Roanoke
On Dec. 6, 2018, the Horace G. Fralin Charitable Trust and Heywood and Cynthia Fralin donated a record…
A UCLA-led research team identified genetic processes involved in the neurodegeneration that occurs in dementiaï¾
On Dec 3, 2018, a University of California, Los Angeles (UCLA) led research team announced they had identified…
University of South Carolina awarded CDC grant to study the risk of human exposure to environmental antibiotic resistant bacteria
On Nov. 30, 2018, Sean Norman, associate professor of environmental health sciences and director of the Molecular Microbial…
Washington University School of Medicine gifted $20 million to boost multiple myeloma research
On Nov. 29, 2018, St. Louis native Rodger Riney and his wife, Paula, donated $20 million to research…
FDA approved gilteritinib, a targeted drug for leukemia tested at UPenn
On Nov. 28, 2018, The U.S. Food and Drug Administration (FDA) announced it had approved the first ever…
Canadian Cancer Trials Group announced IND.234 clinical trial using liquid biopsy technology for prostrate cancer screening
On Nov. 27, 2018, the Canadian Cancer Trials Group announced the IND.234 clinical trial, the first of its…
The Abramson Cancer Center joined the National Comprehensive Cancer Network as its 28th member institution
On Nov. 20, 2018, the Abramson Cancer Center joined the National Comprehensive Cancer Networkï¾® (NCCN) as its 28th…
Pascal Biosciences announced optimization of cannabinoid-derived drug candidates to kill glioblastoma cells
On Nov. 15, 2018, Pascal Biosciences announced the peer reviewed publication of their licensed cannabinoid-derived drug program for…
Prime Minister Trudeau announced federal funding for the Institute for Advanced Medical Isotopes
On Nov. 13, 2018, Canadian Prime Minister Justin Trudeau announced federal funding for the Institute for Advanced Medical…
Mayo Clinic School of Medicine received $200 million gift
On Nov. 13, 2018, the Mayo Clinic announced a gift of $200 million from Jay Alix, noted philanthropist…
Biotechnology | CDC | Disease | Life Science News | Vaccine
ACIP published updated recommendations on use of hepatitis A vaccine for pre- and post-exposure prophylaxis for international travel
On Nov. 2, 2018, the Immunization Practices Advisory Committee (ACIP) published updated recommendations on use of hepatitis A…
AcelRx pharmaceutical DSUVIA was approved by FDA
On Nov. 2, 2018, AcelRx pharmaceutical’s DSUVIA was approved by U.S. Food and Drug Administration (FDA). DSUVIA is…
The Earth BioGenome Project was founded
On Nov. 1, 2018, the Earth BioGenome Project (EBP) was launched, a global effort to sequence the genetic…
Biotechnology | Disease | Life Science History | Life Science News | Non-Profit Research | Therapeutics
City of Hope, TGen announced letter of intent to build cell therapy manufacturing facility in Phoenix area
On Nov. 1, 2018, City of Hope, and its affiliate, Translational Genomics Research Institute (TGen), announced a letter…
Pascal Biosciences and the University of Washington announced exclusive license agreement to develop cannabinoid-based medicine for cancer
On Oct. 30, 2018, Pascal Biosciences announced the Company had entered into an exclusive license agreement with the…
Cacao, the plant from which chocolate is made was domesticated
On Oct. 29, 2018, Archaeological evidence of cacao’s use, dating back to 3,900 years ago, previously planted the…
FNIH Biomarkers Consortium and Critical Path Institute achieve qualification of a clinical safety biomarker
On Oct. 25, 2018, The Foundation for the National Institutes of Health, Biomarkers Consortium and the Critical Path…
The American Dental Association adopted policy to support use and administration of HPV vaccine for the prevention of oral HPV infection
On Oct. 25, 2018, the American Dental Association adopted a policy to support the use and administration of…
The FDA approved a new drug to treat influenza
On Oct. 24, 2018, the U.S. Food and Drug Administration (FDA) announced it had granted approval of Xofluza…
The National Cancer Institute awarded a $10.7 million grant to Abramson Cancer Center to study CAR T cells in solid tumors
On Oct. 22, 2018, the National Cancer Institute awarded a $10.7 million five year grant to Abramson Cancer…
Siteman Cancer Center to offer newest form of proton therapy
On Oct. 22, 2018, the Siteman Cancer Center announced a second proton therapy system that would incorporate pencil-beam…
Genomic analysis offered insight into 2018 Nigeria Lassa fever outbreak
On Oct. 18, 2018, an international team of researchers reported that a surge in Lassa fever cases in…
Discovery Life Sciences expanded by merging with Conversant Bio, Folio Bio, and Phylogeny
On Oct. 16, 2018, Discovery Life Sciences expanded by merging with Conversant Bio, Folio Bio, and Phylogeny to…
The prevalence of U.S. adult smoking declined to 19.3 percent in 2017
On Nov. 9, 2918, the U.S. Centers for Disease Control and Prevention (CDC) reported an estimated 47.4 million…
FDA approved expanded use of Gardasil 9 vaccine to include adults 27 through 45 years old
On Oct. 5, 2018, the FDA announced it had approved a supplemental application for Gardasil 9 (Human Papillomavirus…